A novel cytosolic isoform of mitochondrial trans-2-enoyl-CoA reductase enhances peroxisome proliferator-activated receptor a activity

Dong Gyu Kim, Jae Cheal Yoo, Eunju Kim, Young Sun Lee, Oleg V. Yarishkin, Da Yong Lee, Kun Ho Lee, Seong Geun Hong, Eun Mi Hwang, Jae-Yong Park

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background: Mitochondrial trans-2-enoyl-CoA reductase (MECR) is involved in mitochondrial synthesis of fatty acids and is highly expressed in mitochondria. MECR is also known as nuclear receptor binding factor-1, which was originally reported with yeast two-hybrid screening as a binding protein of the nuclear hormone receptor peroxisome proliferator-activated receptor a (PPARα). However, MECR and PPARα are localized at different compartment, mitochondria, and the nucleus, respectively. Therefore, the presence of a cytosolic or nuclear isoform of MECR is necessary for functional interaction between MECR and PPARα. Methods: To identify the expression pattern of MECR and the cytosolic form of MECR (cMECR), we performed reverse transcription polymerase chain reaction (RT-PCR) with various tissue samples from Sprague-Dawley rats. To confirm the interaction between cMECR and PPARα, we performed several binding assays such as yeast two-hybrid, coimmunoprecipitation, and bimolecular fluorescence complementation. To observe subcellular localization of these proteins, immunocytochemistry was performed. A luciferase assay was used to measure PPARα activity. Results: We provide evidence of an alternatively spliced variant of the rat MECR gene that yields cMECR. The cMECR lacks the N-terminal 76 amino acids of MECR and shows uniform distribution in the cytoplasm and nucleus of HeLa cells. cMECR directly bound PPARα in the nucleus and increased PPARα-dependent luciferase activity in HeLa cells. Conclusion: We found the cytosolic form of MECR (cMECR) was expressed in the cytosolic and/or nuclear region, directly binds with PPARα, and enhances PPARα activity.

Original languageEnglish
Pages (from-to)185-194
Number of pages10
JournalEndocrinology and Metabolism
Volume29
Issue number2
DOIs
Publication statusPublished - 2014 Jan 1
Externally publishedYes

Fingerprint

Fatty Acid Desaturases
Peroxisome Proliferator-Activated Receptors
Protein Isoforms
Luciferases
HeLa Cells
Mitochondria
Yeasts
Cytoplasmic and Nuclear Receptors
Reverse Transcription
Sprague Dawley Rats
Carrier Proteins
Cytoplasm
Fatty Acids
Fluorescence
Immunohistochemistry

Keywords

  • Alternative splicing
  • Cytosolic mitochondrial trans-2-enoyl-CoA reductase
  • Mitochondrial targeting sequences
  • PPAR alpha
  • Trans-2-enoyl-CoA reductase (NADPH)

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

A novel cytosolic isoform of mitochondrial trans-2-enoyl-CoA reductase enhances peroxisome proliferator-activated receptor a activity. / Kim, Dong Gyu; Yoo, Jae Cheal; Kim, Eunju; Lee, Young Sun; Yarishkin, Oleg V.; Lee, Da Yong; Lee, Kun Ho; Hong, Seong Geun; Hwang, Eun Mi; Park, Jae-Yong.

In: Endocrinology and Metabolism, Vol. 29, No. 2, 01.01.2014, p. 185-194.

Research output: Contribution to journalArticle

Kim, Dong Gyu ; Yoo, Jae Cheal ; Kim, Eunju ; Lee, Young Sun ; Yarishkin, Oleg V. ; Lee, Da Yong ; Lee, Kun Ho ; Hong, Seong Geun ; Hwang, Eun Mi ; Park, Jae-Yong. / A novel cytosolic isoform of mitochondrial trans-2-enoyl-CoA reductase enhances peroxisome proliferator-activated receptor a activity. In: Endocrinology and Metabolism. 2014 ; Vol. 29, No. 2. pp. 185-194.
@article{0e799a71f7624bca81e6bdc1077f57d0,
title = "A novel cytosolic isoform of mitochondrial trans-2-enoyl-CoA reductase enhances peroxisome proliferator-activated receptor a activity",
abstract = "Background: Mitochondrial trans-2-enoyl-CoA reductase (MECR) is involved in mitochondrial synthesis of fatty acids and is highly expressed in mitochondria. MECR is also known as nuclear receptor binding factor-1, which was originally reported with yeast two-hybrid screening as a binding protein of the nuclear hormone receptor peroxisome proliferator-activated receptor a (PPARα). However, MECR and PPARα are localized at different compartment, mitochondria, and the nucleus, respectively. Therefore, the presence of a cytosolic or nuclear isoform of MECR is necessary for functional interaction between MECR and PPARα. Methods: To identify the expression pattern of MECR and the cytosolic form of MECR (cMECR), we performed reverse transcription polymerase chain reaction (RT-PCR) with various tissue samples from Sprague-Dawley rats. To confirm the interaction between cMECR and PPARα, we performed several binding assays such as yeast two-hybrid, coimmunoprecipitation, and bimolecular fluorescence complementation. To observe subcellular localization of these proteins, immunocytochemistry was performed. A luciferase assay was used to measure PPARα activity. Results: We provide evidence of an alternatively spliced variant of the rat MECR gene that yields cMECR. The cMECR lacks the N-terminal 76 amino acids of MECR and shows uniform distribution in the cytoplasm and nucleus of HeLa cells. cMECR directly bound PPARα in the nucleus and increased PPARα-dependent luciferase activity in HeLa cells. Conclusion: We found the cytosolic form of MECR (cMECR) was expressed in the cytosolic and/or nuclear region, directly binds with PPARα, and enhances PPARα activity.",
keywords = "Alternative splicing, Cytosolic mitochondrial trans-2-enoyl-CoA reductase, Mitochondrial targeting sequences, PPAR alpha, Trans-2-enoyl-CoA reductase (NADPH)",
author = "Kim, {Dong Gyu} and Yoo, {Jae Cheal} and Eunju Kim and Lee, {Young Sun} and Yarishkin, {Oleg V.} and Lee, {Da Yong} and Lee, {Kun Ho} and Hong, {Seong Geun} and Hwang, {Eun Mi} and Jae-Yong Park",
year = "2014",
month = "1",
day = "1",
doi = "10.3803/EnM.2014.29.2.185",
language = "English",
volume = "29",
pages = "185--194",
journal = "Endocrinology and Metabolism",
issn = "2093-596X",
publisher = "Korean Endocrine Society",
number = "2",

}

TY - JOUR

T1 - A novel cytosolic isoform of mitochondrial trans-2-enoyl-CoA reductase enhances peroxisome proliferator-activated receptor a activity

AU - Kim, Dong Gyu

AU - Yoo, Jae Cheal

AU - Kim, Eunju

AU - Lee, Young Sun

AU - Yarishkin, Oleg V.

AU - Lee, Da Yong

AU - Lee, Kun Ho

AU - Hong, Seong Geun

AU - Hwang, Eun Mi

AU - Park, Jae-Yong

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Background: Mitochondrial trans-2-enoyl-CoA reductase (MECR) is involved in mitochondrial synthesis of fatty acids and is highly expressed in mitochondria. MECR is also known as nuclear receptor binding factor-1, which was originally reported with yeast two-hybrid screening as a binding protein of the nuclear hormone receptor peroxisome proliferator-activated receptor a (PPARα). However, MECR and PPARα are localized at different compartment, mitochondria, and the nucleus, respectively. Therefore, the presence of a cytosolic or nuclear isoform of MECR is necessary for functional interaction between MECR and PPARα. Methods: To identify the expression pattern of MECR and the cytosolic form of MECR (cMECR), we performed reverse transcription polymerase chain reaction (RT-PCR) with various tissue samples from Sprague-Dawley rats. To confirm the interaction between cMECR and PPARα, we performed several binding assays such as yeast two-hybrid, coimmunoprecipitation, and bimolecular fluorescence complementation. To observe subcellular localization of these proteins, immunocytochemistry was performed. A luciferase assay was used to measure PPARα activity. Results: We provide evidence of an alternatively spliced variant of the rat MECR gene that yields cMECR. The cMECR lacks the N-terminal 76 amino acids of MECR and shows uniform distribution in the cytoplasm and nucleus of HeLa cells. cMECR directly bound PPARα in the nucleus and increased PPARα-dependent luciferase activity in HeLa cells. Conclusion: We found the cytosolic form of MECR (cMECR) was expressed in the cytosolic and/or nuclear region, directly binds with PPARα, and enhances PPARα activity.

AB - Background: Mitochondrial trans-2-enoyl-CoA reductase (MECR) is involved in mitochondrial synthesis of fatty acids and is highly expressed in mitochondria. MECR is also known as nuclear receptor binding factor-1, which was originally reported with yeast two-hybrid screening as a binding protein of the nuclear hormone receptor peroxisome proliferator-activated receptor a (PPARα). However, MECR and PPARα are localized at different compartment, mitochondria, and the nucleus, respectively. Therefore, the presence of a cytosolic or nuclear isoform of MECR is necessary for functional interaction between MECR and PPARα. Methods: To identify the expression pattern of MECR and the cytosolic form of MECR (cMECR), we performed reverse transcription polymerase chain reaction (RT-PCR) with various tissue samples from Sprague-Dawley rats. To confirm the interaction between cMECR and PPARα, we performed several binding assays such as yeast two-hybrid, coimmunoprecipitation, and bimolecular fluorescence complementation. To observe subcellular localization of these proteins, immunocytochemistry was performed. A luciferase assay was used to measure PPARα activity. Results: We provide evidence of an alternatively spliced variant of the rat MECR gene that yields cMECR. The cMECR lacks the N-terminal 76 amino acids of MECR and shows uniform distribution in the cytoplasm and nucleus of HeLa cells. cMECR directly bound PPARα in the nucleus and increased PPARα-dependent luciferase activity in HeLa cells. Conclusion: We found the cytosolic form of MECR (cMECR) was expressed in the cytosolic and/or nuclear region, directly binds with PPARα, and enhances PPARα activity.

KW - Alternative splicing

KW - Cytosolic mitochondrial trans-2-enoyl-CoA reductase

KW - Mitochondrial targeting sequences

KW - PPAR alpha

KW - Trans-2-enoyl-CoA reductase (NADPH)

UR - http://www.scopus.com/inward/record.url?scp=84975769832&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84975769832&partnerID=8YFLogxK

U2 - 10.3803/EnM.2014.29.2.185

DO - 10.3803/EnM.2014.29.2.185

M3 - Article

VL - 29

SP - 185

EP - 194

JO - Endocrinology and Metabolism

JF - Endocrinology and Metabolism

SN - 2093-596X

IS - 2

ER -